Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• T cell activation is critical for adaptive immunity and relies on MAPK signaling pathways.
• Dual-specificity phosphatase 14 (DUSP14) is a MAPK phosphatase, but its in vivo function in T cells is largely unknown.
• Understanding DUSP14's role is key to deciphering immune response regulation.

Purpose of the Study:

• To investigate the in vivo function of DUSP14 in T cell activation and immune responses.
• To elucidate the molecular mechanism by which DUSP14 regulates T cell signaling.
• To determine the impact of DUSP14 deficiency on autoimmune disease models.

Main Methods:

• Generation and characterization of DUSP14-deficient mice.
• Analysis of T cell proliferation and cytokine production in vitro and in vivo.
• Investigation of protein-protein interactions and phosphorylation status of signaling molecules (TAB1, TAK1, JNK, IκB kinase).
• Utilized short hairpin RNA (shRNA) knockdown of TAB1.

Main Results:

• DUSP14-deficient T cells exhibited enhanced proliferation and cytokine production upon activation.
• DUSP14 directly dephosphorylated TAB1 at Ser(438), leading to inactivation of the TAB1-TAK1 complex.
• Enhanced phosphorylation of TAB1-TAK1 and downstream kinases (JNK, IκB kinase) was observed in DUSP14-deficient T cells.
• DUSP14-deficient mice showed heightened immune responses and increased susceptibility to experimental autoimmune encephalomyelitis (EAE).

Conclusions:

• DUSP14 acts as a negative regulator of T cell receptor (TCR) signaling.
• DUSP14 inhibits T cell activation and immune responses by deactivating the TAB1-TAK1 complex.
• DUSP14 deficiency leads to exaggerated immune responses and susceptibility to autoimmune diseases like EAE.